Alport Syndrome
📧 Sign up to get email alerts when something new happens for Alport Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT) [Phase 4]
Phase 4 trial evaluating whether dapagliflozin, spironolactone, or their combination lowers albuminuria in adults with Alport syndrome and r…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study to Evaluate Setanaxib in Patients With Alport Syndrome [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating setanaxib in patients with Alport syndrome has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: A Study of ELX-02 in Patients With Alport Syndrome [Phase 2]
A Phase 2 study evaluating ELX-02 in patients with Alport Syndrome has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1) [Phase 2]
A Phase 2 trial (ALPESTRIA-1) evaluated the safety and efficacy of vonafexor for Alport Syndrome and has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Alport Syndrome Treatments and Outcomes Registry
The University of Minnesota completed the Alport Syndrome Treatments and Outcomes Registry, a clinical trial registry tracking treatments an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis [Phase 2]
Phase 2 study evaluating R3R01 in patients with Alport syndrome and focal segmental glomerulosclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) [Phase 3]
The Phase 3 extended access program for bardoxolone methyl in chronic kidney disease was terminated, with results posted in March 2024. The …
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Study of Lademirsen (SAR339375) in Patients With Alport Syndrome [Phase 2]
This is a Phase 2 clinical trial update for Lademirsen (SAR339375) in Alport syndrome. The study has been terminated and results have been p…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL [Phase 2, Phase 3]
A Phase 2/3 trial (CARDINAL) evaluating Bardoxolone methyl for Alport syndrome has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome [Phase 2]
Phase 2 clinical trial evaluating intensified treatment with ACE inhibitors, AT1 receptor blockers, and statins for Alport Syndrome has comp…
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: Treatment With Metformin in Chinese Children With Alport Syndrome [Phase 4]
Phase 4 clinical trial evaluating metformin in Chinese children with Alport syndrome.
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome [Phase 3]
Phase 3 trial update evaluating efficacy and safety to delay renal failure in children with Alport syndrome.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome
This ClinicalTrials.gov update reports on a prospective study assessing microalbuminuria in untreated boys with Alport syndrome; the trial i…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Urinary Biomarkers of the Progression of Alport Kidney Disease
A completed clinical trial update assessing urinary biomarkers to track progression in Alport syndrome.